Validation

Multi-site Reference Intervals

While attending the September 12–15, 2017 Mayo Medical Laboratory conference, Bleeding and Thrombosing Diseases George spoke with Susan Hollister and Jennifer Rider from Sanford Health in Fargo. Susan and Jen are developing reference intervals for their coagulation laboratory services throughout Sanford’s system and are looking for a reasonable approach that combines satellite resources with the […]

Medical Decision Points

Odetta Hanna from Sekisui Diagnostics asked, “Do you have a good resource to obtain the medical decision points for coagulation assays?” From George, yes, the text I find most helpful for clinical decision-making is Kitchens CS, Kessler CM, Konkie BA. Consultative Hemostasis and Thrombosis, Third Edition, 2013, Elsevier, Philadelphia. Also, if you pardon the self-promotion, […]

Global Hemostasis Assays

How Many QC Repetitions?

From Heather DeVries at Indiana University Health. Hello George! In a system meeting recently, our procedure for evaluating new lot calibrator material was discussed. Currently, we require sites to run 5 points of QC after calibrating with a new lot. If the mean of those 5 points is within 20% of the established mean, we […]

PT and PTT Reference Interval

Here are the results of our latest Quick Question: How many normal subject specimens do you collect to establish a PT and PTT reference interval? a. 240: 7 votes, 3% b. 120: 79 votes, 35% c. 30: 51 votes, 23% d. 20: 79 votes, 35% e. Other: 9 votes, 4% Comments excerpted from Fritsma GA. […]

Quick Question Archive

More on Validations Using Commercial Plasmas

John Olson, MD, provides his position on the use of commercial plasmas for lot-to-lot validations (rollover) and for establishing reference intervals. Though associated with CAP, Dr. Olson’s opinion does not necessarily reflect the official CAP policy. “I would not have difficulty with a laboratory using commercial sets for determining reference interval. By far the best […]

Subjects in Reference Interval Study

Mona Murphy, Pathology Laboratory, Lewiston, ME reports using 20 males and 20 females in a normal range study.

Quick Question Archive

Validations Using Commercial Plasmas

Chris Powell at King’s Daughters’ Health asks: commercial plasma distributors offer pre-screened patient specimens for PT and PTT lot rollover. How can this product be used and still meet the CAP and CLIA requirement to collect specimens from your own patient population? Hi, Chris, thank you for your question. I’ve modified your reference to a […]

PNP: How Many Donors?

From Dr. Tang: Dear George, In the mixing test, commonly 20 healthy donors is required for preparing normal pooled plasma, why not 15, 10, or 5 donors? Have any studies validated that? Thank you for your reply. Hello, Dr. Tang. I know of no published studies that establish 20 donors as a minimum for producing […]

Specimen Management

Elevated Protein C Activity

From colleague and friend Kelly Townsend, Tricore Laboratories, Albuquerque: We periodically see elevated protein C activity results in our rheumatology patients. We’ve been wondering what might be leading to this finding. They do not all have positive LA, and in fact tend to have PTT‘s in the lower half of the reference interval (sometimes quite […]

Lupus Anticoagulant

APCR Controls

From Sheila Minor: We are currently using the Chromogenix Coatest APC Resistance VS kit for APCR testing. Chromogenix provides 1 set of level 1 and level 2 controls in each kit. The instructions state that the controls may be refrozen one time at –20 C or colder in their original vials. That would be fine if we used […]

Load more

George Fritsma is a medical laboratory scientist, educator, and author. George holds faculty appointments with Rutgers University and Michigan State University, and is a member of the International Society on Thrombosis and Hemostasis, American Association of Clinical Chemists, and American Society for Clinical Laboratory Science.

Cheat Sheets from George

Quick Question